Centogene (CNTGF, $0.15) was one of top quarterly gainers, jumping +1 to $0.15 per share. A.I.dvisor analyzed 408 stocks in the Medical Specialties Industry over the last three months, and discovered that of them (4) charted an Uptrend while of them (5) trended down.
a commercial-stage company, which focuses on rare diseases that transform real-world clinical and genetic data into actionable information for patients, physicians and pharmaceutical companies